Indaptus Therapeutics, Inc.

Biotechnology • Healthcare • New York, NY, United States • INDP (NCM)

Indaptus Therapeutics, Inc., a clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical candidate consists of Decoy20, which is used to produce single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, and chronic hepatitis B virus, and human immunodeficiency virus infection, as well as for the treatment of advanced solid tumors. The company was formerly known as Intec Parent, Inc. and changed its name to Indaptus Therapeutics, Inc. in August 2021. Indaptus Therapeutics, Inc. is headquartered in New York, New York.

Stock Performance (90 Days)

Data through Dec 26, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Three Indaptus Therapeutics board members signal planned resignations - Investing.com

Investing.com • Jan 2

Indaptus Therapeutics (INDP) Stock in Focus on Dec. 24, 2025: $6M Financing, Leadership Reset, and the Dilution Question - ts2.tech

ts2.tech • Dec 24

Indaptus Therapeutics announces upcoming board leadership transition - TipRanks

TipRanks • Jan 2

Why Did Indaptus Therapeutics Surge 64% In After-Hours Trading? - Sahm

Sahm • Dec 24

Indaptus Therapeutics looks to raise $2.25M in private placement - MSN

MSN • Dec 31

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Indaptus Therapeutics, Inc. had layoffs?

No layoff events have been recorded for Indaptus Therapeutics, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Indaptus Therapeutics, Inc. have?

Indaptus Therapeutics, Inc. has approximately 7 employees.

What industry is Indaptus Therapeutics, Inc. in?

Indaptus Therapeutics, Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is Indaptus Therapeutics, Inc. a publicly traded company?

Yes, Indaptus Therapeutics, Inc. is publicly traded under the ticker symbol INDP on the NCM. The company has a market capitalization of approximately $0.00 billion.

Where is Indaptus Therapeutics, Inc. headquartered?

Indaptus Therapeutics, Inc. is headquartered in New York, NY, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.